Synfacts, Table of Contents Synfacts 2023; 19(01): 0095DOI: 10.1055/s-0042-1752381 Innovative Drug Discovery and Development Overcoming Antimicrobial Resistance: Rational Design of Rifamycin Antibiotics Contributor(s): Antonia F. Stepan (Roche) , Danica A. Rankic (Pfizer) , Nadine Kuhl (MSD) Recommend Article Abstract Buy Article Key words Key wordsantimicrobial resistance - rifamycin - rational drug design Full Text